Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the U.S. Food and Drug ...

SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...

Additional Phase 2 data for vilastobart,a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with MSS CRC ...

Key products like Tyvaso and Orenitram showed strong revenue increases. The company continues to advance its pipeline with significant clinical trial progress. United Therapeutics achieved record ...

The company continues to advance its pipeline with significant clinical trial progress. United Therapeutics achieved record revenue growth in 2024, marking the third consecutive year of such ...

Axsome Therapeutics, Inc. (NASDAQ ... With a robust product portfolio and promising pipeline, Axsome has captured the attention of investors and analysts alike, building a market capitalization ...

Eikon Therapeutics has secured $350.7 million in Series D financing to advance its clinical stage programs and expand its pipeline. The latest funding round brings the company’s total private funding ...

Feb. 26, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced solid tumors and autoimmune diseases, today announced a ...

--(BUSINESS WIRE)--#Biotech--Eikon Therapeutics, Inc., a pivotal-stage biotechnology ... “Eikon has made remarkable progress in advancing a pivotal-stage clinical pipeline and early-stage development ...

KRAKOW, Poland, Feb. 25, 2025 /PRNewswire/ -- Ryvu Therapeutics (WSE ... focus on driving the RVU120 clinical program and the early pipeline to key data inflection points. Paweł ...